WebDisclosure WebDisclosure
Basculer en Français
9554 Companies
188644 Keywords
120427 Articles
100705 Press releases
Headlines Articles Press releases Dr. Falk Pharma GmbH Remove
  1. Home
  2. Companies
  3. Dr. Falk Pharma GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/29/2024 at 13:05, 1 year 1 month ago

    Dr. Falk Pharma Acquires Kynos Therapeutics, Enhancing Portfolio in Inflammatory Diseases

    Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
  • BRIEF

    published on 10/29/2024 at 13:05, 1 year 1 month ago

    Dr. Falk Pharma acquiert Kynos Therapeutics, enrichissant ainsi son portefeuille dans le domaine des maladies inflammatoires

    Maladies Inflammatoires Dr. Falk Pharma KNS366 Thérapeutique Kynos Pancréatite Aiguë
  • PRESS RELEASE

    published on 10/29/2024 at 13:00, 1 year 1 month ago

    Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio

    Dr. Falk Pharma GmbH acquires Kynos Therapeutics Ltd., focusing on inflammatory disease treatments. KNS366, a novel enzyme inhibitor, shows promise in clinical trials for acute pancreatitis
    Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
    Logo of Dr. Falk Pharma GmbH
Accesswire
  • Published on 12/19/2025 at 03:15, 7 hours 17 minutes ago

    Tactical Resources Announces Receipt Of Final Order Approving Arrangement With Plum Acquisition Corp. III

  • Published on 12/19/2025 at 01:10, 9 hours 22 minutes ago

    Ostrom Climate Exits Existing UPRIIS ERPA Arrangements

  • Published on 12/19/2025 at 01:00, 9 hours 32 minutes ago

    Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited

  • Published on 12/19/2025 at 00:50, 9 hours 42 minutes ago

    High Resolution Gravity Survey Targets Challenger Repeats

  • Published on 12/19/2025 at 00:00, 10 hours 32 minutes ago

    LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor

View all ACCESSWIRE
EQS Group
  • Published on 12/19/2025 at 10:00, 32 minutes ago

    Partners Group to sell stake in Australian wind farm

  • Published on 12/19/2025 at 09:35, 57 minutes ago

    Top sports physio says football bosses failing to properly protect players' health this Christmas as injuries expected to rise

  • Published on 12/19/2025 at 09:31, 1 hour ago

    Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY

  • Published on 12/19/2025 at 09:26, 1 hour 5 minutes ago

    Original-Research: SYNBIOTIC SE (von NuWays AG): BUY

  • Published on 12/19/2025 at 09:21, 1 hour 10 minutes ago

    Original-Research: Netfonds AG (von NuWays AG): BUY

View all EQS
Les Echos
  • Published on 12/19/2025 at 08:30, 2 hours 2 minutes ago

    Share capital decrease by way of treasury shares cancellation

  • Published on 12/19/2025 at 08:30, 2 hours 2 minutes ago

    Réduction du capital par voie d’annulation d’actions propres

  • Published on 12/19/2025 at 07:00, 3 hours 32 minutes ago

    EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS

  • Published on 12/19/2025 at 07:00, 3 hours 32 minutes ago

    EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

  • Published on 12/18/2025 at 18:30, 16 hours 2 minutes ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy